• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New era: prospects for managing cancer of unknown primary.

作者信息

Li Yize, Bai Yinmiao, Ji Hongchen, Liu Zhihui, Zhang Hongmei

机构信息

Department of Clinical Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.

出版信息

Cancer Biol Med. 2023 Aug 26;20(8):562-7. doi: 10.20892/j.issn.2095-3941.2023.0168.

DOI:10.20892/j.issn.2095-3941.2023.0168
PMID:37646233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10476467/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314d/10476467/6775f70def72/cbm-20-562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314d/10476467/e8a0b023d7a4/cbm-20-562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314d/10476467/6775f70def72/cbm-20-562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314d/10476467/e8a0b023d7a4/cbm-20-562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314d/10476467/6775f70def72/cbm-20-562-g002.jpg

相似文献

1
New era: prospects for managing cancer of unknown primary.新时代：未知原发灶癌症的管理前景
Cancer Biol Med. 2023 Aug 26;20(8):562-7. doi: 10.20892/j.issn.2095-3941.2023.0168.
2
Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.原发部位不明的癌症：精准医学时代的新治疗模式
Am Soc Clin Oncol Educ Book. 2018 May 23;38:20-25. doi: 10.1200/EDBK_100014.
3
[Cancer of unknown origin].[原发灶不明的癌症]
Med Clin (Barc). 2007 Jun 2;129(1):23-6. doi: 10.1157/13106677.
4
[Diagnostic and therapeutic approach in cancer of metastatic presentation and unknown origin].[转移性表现且原发灶不明的癌症的诊断与治疗方法]
Rev Clin Esp. 2002 Nov;202(11):604-14.
5
Carcinoma of unknown primary site.原发部位不明的癌。
N Engl J Med. 2014 Nov 20;371(21):2040. doi: 10.1056/NEJMc1411384.
6
Carcinoma of unknown primary site.原发部位不明的癌。
N Engl J Med. 2014 Nov 20;371(21):2039. doi: 10.1056/NEJMc1411384.
7
Carcinoma of unknown primary site.原发部位不明的癌。
N Engl J Med. 2014 Nov 20;371(21):2039-40. doi: 10.1056/NEJMc1411384.
8
The dilemma of evaluating and treating cancer of unknown primary site.评估和治疗原发部位不明癌症的困境。
Cleve Clin J Med. 1997 Feb;64(2):73-5. doi: 10.3949/ccjm.64.2.73.
9
Cancer of unknown primary site.原发部位不明的癌症。
N Engl J Med. 2014 Aug 21;371(8):757-65. doi: 10.1056/NEJMra1303917.
10
Cancer from an unknown primary site.原发部位不明的癌症。
Am J Med Sci. 2003 Jul;326(1):35-46. doi: 10.1097/00000441-200307000-00006.

本文引用的文献

1
From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.从生物学到诊断与治疗：不明原发灶癌的阿里阿德涅之线。
Int J Mol Sci. 2023 Mar 15;24(6):5588. doi: 10.3390/ijms24065588.
2
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.被转诊至区域癌症中心的不明原发灶癌或未确定原发灶恶性肿瘤患者的临床结局。
Int J Clin Oncol. 2023 May;28(5):644-653. doi: 10.1007/s10147-023-02316-y. Epub 2023 Mar 10.
3
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
原发灶不明癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Mar;34(3):228-246. doi: 10.1016/j.annonc.2022.11.013. Epub 2022 Dec 20.
4
International consensus on the initial diagnostic workup of cancer of unknown primary.关于原发灶不明癌症初始诊断检查的国际共识。
Crit Rev Oncol Hematol. 2023 Jan;181:103868. doi: 10.1016/j.critrevonc.2022.103868. Epub 2022 Nov 23.
5
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.比较 DNA 测序和基因表达谱分析以辅助不明原发癌的组织起源诊断。
J Pathol. 2023 Jan;259(1):81-92. doi: 10.1002/path.6022. Epub 2022 Nov 30.
6
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.肿瘤标志物在识别不明原发癌患者中有利或不利亚组的诊断价值：一项回顾性研究。
BMC Cancer. 2022 Apr 14;22(1):412. doi: 10.1186/s12885-022-09514-3.
7
Site-specific therapy in cancers of unknown primary site: a systematic review and meta-analysis.不明原发灶肿瘤的局部治疗：系统评价和荟萃分析。
ESMO Open. 2022 Apr;7(2):100407. doi: 10.1016/j.esmoop.2022.100407. Epub 2022 Mar 3.
8
Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary.开放标签 II 期研究纳武利尤单抗治疗不明原发癌的疗效。
Ann Oncol. 2022 Feb;33(2):216-226. doi: 10.1016/j.annonc.2021.11.009. Epub 2021 Nov 26.
9
Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary.不明原发癌中循环游离 DNA 改变的治疗可操作性。
JCO Precis Oncol. 2021 Nov 3;5. doi: 10.1200/PO.21.00011. eCollection 2021.
10
AI-based pathology predicts origins for cancers of unknown primary.基于人工智能的病理学预测癌症未知原发灶的起源。
Nature. 2021 Jun;594(7861):106-110. doi: 10.1038/s41586-021-03512-4. Epub 2021 May 5.